ES2184299T3 - Factores tisulares destinados a influenciar la vascularizacion. - Google Patents

Factores tisulares destinados a influenciar la vascularizacion.

Info

Publication number
ES2184299T3
ES2184299T3 ES98933500T ES98933500T ES2184299T3 ES 2184299 T3 ES2184299 T3 ES 2184299T3 ES 98933500 T ES98933500 T ES 98933500T ES 98933500 T ES98933500 T ES 98933500T ES 2184299 T3 ES2184299 T3 ES 2184299T3
Authority
ES
Spain
Prior art keywords
tissular
vascularization
influence
factors intended
factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98933500T
Other languages
English (en)
Inventor
Peter Nawroth
Katsumi Nakagawa
Youming Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merckle GmbH
Original Assignee
Merckle GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle GmbH filed Critical Merckle GmbH
Application granted granted Critical
Publication of ES2184299T3 publication Critical patent/ES2184299T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Instructional Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invención se refiere a la utilización de tromboplastina tisular para favorecer, y particularmente activar la formación vascular, en particular para la cura de heridas.
ES98933500T 1997-05-09 1998-05-08 Factores tisulares destinados a influenciar la vascularizacion. Expired - Lifetime ES2184299T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19719652A DE19719652A1 (de) 1997-05-09 1997-05-09 Tissue-Faktor zur Förderung von Wundheilung
DEPCT/DE98/01278 1998-05-07

Publications (1)

Publication Number Publication Date
ES2184299T3 true ES2184299T3 (es) 2003-04-01

Family

ID=7829124

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98933500T Expired - Lifetime ES2184299T3 (es) 1997-05-09 1998-05-08 Factores tisulares destinados a influenciar la vascularizacion.

Country Status (16)

Country Link
EP (1) EP0980251B1 (es)
JP (1) JP2001527555A (es)
AT (1) ATE222501T1 (es)
AU (1) AU746782B2 (es)
CA (1) CA2288117A1 (es)
CZ (1) CZ293005B6 (es)
DE (2) DE19719652A1 (es)
DK (1) DK0980251T3 (es)
ES (1) ES2184299T3 (es)
HU (1) HUP0003831A3 (es)
IS (1) IS5231A (es)
NO (1) NO995459D0 (es)
PL (1) PL336662A1 (es)
PT (1) PT980251E (es)
SI (1) SI0980251T1 (es)
WO (1) WO1998051321A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749498B2 (en) 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
US20030109680A1 (en) 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
DE19719652A1 (de) * 1997-05-09 1998-12-03 Merckle Gmbh Tissue-Faktor zur Förderung von Wundheilung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
WO1994005328A1 (en) * 1992-08-28 1994-03-17 The Scripps Research Institute Inhibition of tumor metastasis via neutralization of tissue factor function
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
NZ271488A (en) * 1994-07-12 1998-01-26 Human Genome Sciences Inc Connective tissue growth factor-2 (ctgf-2)
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
DE19719652A1 (de) * 1997-05-09 1998-12-03 Merckle Gmbh Tissue-Faktor zur Förderung von Wundheilung

Also Published As

Publication number Publication date
AU8331598A (en) 1998-12-08
JP2001527555A (ja) 2001-12-25
CA2288117A1 (en) 1998-11-19
PL336662A1 (en) 2000-07-03
DE19719652A1 (de) 1998-12-03
SI0980251T1 (en) 2003-02-28
PT980251E (pt) 2003-01-31
DE59805246D1 (de) 2002-09-26
AU746782B2 (en) 2002-05-02
NO995459L (no) 1999-11-08
HUP0003831A3 (en) 2003-08-28
EP0980251B1 (de) 2002-08-21
WO1998051321A1 (de) 1998-11-19
DK0980251T3 (da) 2002-11-18
IS5231A (is) 1999-10-26
WO1998051321A9 (de) 1999-04-01
CZ391299A3 (cs) 2000-04-12
ATE222501T1 (de) 2002-09-15
EP0980251A1 (de) 2000-02-23
CZ293005B6 (cs) 2004-01-14
NO995459D0 (no) 1999-11-08
HUP0003831A2 (hu) 2001-02-28

Similar Documents

Publication Publication Date Title
WO2000073418A3 (en) A method of using autologous fibroblasts to promote healing of wounds and fistulas
IS2505B (is) Speglunarskuggaefni, sem helst lengi í blóði, til sjúkdómsgreininga
GR890100652A (el) Οφθαλμικη ραφη και οργανα για την εφαρμογη χρησεως της ραφης.
BR9902457A (pt) Padrões de adesivo aperfeiçoados para artigos de higiene feminina.
ES2187665T3 (es) Uso de la il-10 para curar heridas con una cicatrizacion reducida.
SE9702860D0 (sv) New use
DE69937562D1 (de) Verbessertes angereichertes blutplättchen wundheilmittel
ES2134468T3 (es) Preparado de colageno para la liberacion controlada de principios activos.
FI970747A (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
FR2772618B1 (fr) Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
DK0955515T3 (da) Væv, især stikbeskyttende væv
ES2184299T3 (es) Factores tisulares destinados a influenciar la vascularizacion.
DK0841931T3 (da) Farmaceutisk sammensætning
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
PT841937E (pt) Utilizacao de betaglicano para reduzir a formacao de cicatrizes
DK1115375T3 (da) Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
TR199800168A2 (xx) �nsan endoglin geni y�kselticisi ve kullan�m�.
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
WO1999049895A3 (en) Method for increasing the permeability of horny human tissue
NO984965D0 (no) Komponent B som cicatrisant
GB9812278D0 (en) Use of a wound dressing in the treatment of acute wounds
FR2744907B1 (fr) Ligament artificiel, notamment pour la cheville
ITVR940027A0 (it) Procedimento di endotelizzazione in vitro per protesi vascolari e val-volari.
ES1039587Y (es) Receptaculo-protector para conservacion, mantenimiento, higiene y asepsia de profesis dentales.